Reversible posterior leukoencephalopathy syndrome and bevacizumab. [electronic resource]
Producer: 20060307Description: 980-2; discussion 980-2 p. digitalISSN:- 1533-4406
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Brain -- pathology
- Female
- Humans
- Hypertensive Encephalopathy -- chemically induced
- Kidney Neoplasms -- drug therapy
- Magnetic Resonance Imaging
- Middle Aged
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.